Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Inserm (Inst.Nat.de la Sante et de la Rech.Med.

Paris, FR

Inserm (Inst.Nat.de la Sante et de la Rech.Med. Patent applications
Patent application numberTitlePublished
20080242601Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization - The present invention relates to polypeptides that inhibit the NF-&kgr; B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.10-02-2008